Editas Medicine, Inc.
EDIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$237 | -$153 | -$220 | -$193 |
| Dep. & Amort. | $6 | $6 | $6 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $21 | $20 | $29 | $43 |
| Change in WC | $3 | -$2 | $8 | -$21 |
| Other Non-Cash | -$4 | -$3 | -$1 | $2 |
| Operating Cash Flow | -$210 | -$132 | -$177 | -$164 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$5 | -$4 | -$8 |
| Net Acquisitions | $0 | $0 | $0 | $46 |
| Inv. Purchases | -$86 | -$259 | -$315 | -$409 |
| Inv. Sales/Matur. | $257 | $260 | $433 | $362 |
| Other Inv. Act. | $0 | $0 | $0 | -$46 |
| Investing Cash Flow | $162 | -$4 | $114 | -$54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $56 | $117 | $1 | $249 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $0 | $33 |
| Financing Cash Flow | $56 | $118 | $1 | $282 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | -$18 | -$62 | $64 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $128 | $145 | $207 | $144 |
| End Cash | $135 | $128 | $145 | $207 |
| Free Cash Flow | -$219 | -$137 | -$181 | -$172 |